Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Déduit des transports déclarés par cette annonce (streamable-http). Un client absent de cette liste n’est pas écarté pour autant — c’est simplement quelque chose que Forge ne peut pas confirmer.
La vérification confirme l’identité de l’éditeur (la propriété du dépôt), pas la sûreté du code. L’analyse de sécurité couvre les CVE connues et les scripts d’installation suspects.
Lu depuis un véritable échange MCP initialize → tools/list contre l’endpoint déclaré. Aucun outil n’a été invoqué — tools/list est l’appel d’introspection en lecture seule que le protocole prévoit pour cela. Cela reflète ce que le serveur annonçait à cet instant ; un endpoint hébergé n’est figé sur aucune version et peut changer sans préavis.
https://www.coverage-rights.com/api/mcp9 outils · 246 mslist_insurersList tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each.
Aucun schéma d’entrée n’a été publié pour cet outil.
get_insurer_metricsGet an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes.
| Paramètre | Type | Description |
|---|---|---|
| slug* | string | Insurer slug from list_insurers, e.g. 'unitedhealthcare' |
rank_denial_ratesInsurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts.
Aucun schéma d’entrée n’a été publié pour cet outil.
get_treatment_outcomesExternal-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy').
| Paramètre | Type | Description |
|---|---|---|
| slug* | string | Treatment slug, e.g. 'zepbound', 'pharmacy', 'speech-therapy'. Use search_outcomes to find slugs. |
get_condition_outcomesExternal-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it.
| Paramètre | Type | Description |
|---|---|---|
| slug* | string | Condition slug, e.g. 'obesity', 'autism', 'hepatitis-c' |
search_outcomesSearch treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates.
| Paramètre | Type | Description |
|---|---|---|
| query* | string | Search text, e.g. 'wegovy', 'back pain', 'imaging' |
| limit | integer | Max results per type (default 10) |
get_appeal_rightsDeterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, T…
| Paramètre | Type | Description |
|---|---|---|
| program* | string | Plan type |
| denial_reason* | string | Denial reason category. Use 'prescription-drug' for medication denials — formulary exclusion, step therapy, quantity limits, or drug prior authorization — whic… |
| state | string | Two-letter state code, e.g. 'ca' |
| insurer_slug | string | Insurer slug for insurer-specific stats |
| employer_type | string | Required to resolve job-based coverage |
| funding_status | string | Required to resolve job-based state versus federal governance |
| drug_channel | string | For a drug denial, whether the medical or pharmacy benefit applies |
| regulatory_marker | string | — |
| regulatory_state_basis | string | — |
| appeal_stage | string | — |
| current_status | string | — |
get_drug_playbookDrug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that…
| Paramètre | Type | Description |
|---|---|---|
| drug* | string | Brand or generic drug name, e.g. 'Zepbound', 'ustekinumab' |
get_state_external_reviewHow a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list.
| Paramètre | Type | Description |
|---|---|---|
| state* | string | Two-letter state code, e.g. 'ca', 'ny', 'fl' |
9 outils sur 9 ont publié une description.
Les noms et descriptions d’outils sont écrits par l’éditeur et affichés tels quels, comme du texte inerte. Ce sont les chaînes qu’un client MCP transmet à un modèle, alors Forge y recherche des motifs d’injection de prompt — tout constat apparaît avec l’analyse de sécurité ci-dessus. « Privilégié » est une correspondance de mot-clé sur le nom de l’outil, pas un audit de ce qu’il fait : un nom anodin peut tout de même tout faire.
Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
Les noms cliquables ouvrent l’index Forge de toutes les entrées observées exposant cet outil. Parcourir tous les outils indexés.
Cette entrée ne publie aucun paquet npm : Forge n'a donc pas d'arbre de dépendances pour elle. C'est une lacune de couverture — pas une affirmation qu'elle n'a aucune dépendance.